HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

482.357

-14.363-2.89%

Number of Gainers:12

Number of Losers:18

Number of Flat:3

PE:- -

High:497.296

Open:496.590

Low:481.390

Close:496.720

Volume:78.29M

Turnover:2.16B

Market Cap:306.78B

Float Cap:272.65B

Loading ...

ZYLOXTB (02190) Spends Approximately HK$1.13 Million on Share Buyback on September 15

HK Stocks in Focus: HEART CARE-B Surges Over 5% on Robust H1 Growth and A-Share Listing Plans

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

Channel Edge Fades, Active Research Lags: Who Can Fill ICBC Credit Suisse's Equity Gap?

Jefferies Reaffirms Bullish Stance on AKESO, Sets Price Target at HK$226

Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine

Hong Kong Stock Flash | TYK Medicines-B (02410) Surges Over 10% as Major Shareholder's Buyback Lifts Sentiment, Following Key Drug Approval

Jefferies Highlights Positive HARMONi-2 Results for AKESO, Reaffirms Buy Rating with HK$226 Target

GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

EDDING GENOR Spends Approximately HK$1.70 Million on Share Buyback on September 14

CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

HEARTCARE-B Grants 560,000 Share Awards Under 2025 Incentive Scheme

Edding Genor Board Chair and CEO Boosts Stake with 200,000-Share Purchase at $1.74 Each

ALPHAMAB-B (09966) Allocates Approximately HK$796,300 for Share Buyback on September 14

Market Consolidation with Low Volume: Innovative Drugs Surge Against the Trend, Banking Index Hits New Annual High, Optical Module Leaders Retreat While Capital Seeks Opportunities in High-Optical ETFs

ETF Market Recap: Short-Term Opportunities Emerge in Previously Corrected Innovative Drug and CXO Sectors Amidst Soft Broader Market Momentum

National Healthcare Security Administration Releases Roster of Pharmaceutical Firms With 'Severe' and 'Extremely Severe' Credit Violations

Hengrui's Novel Factor XI Monoclonal Antibody Wins NMPA Acceptance for VTE Prevention in Elective Knee Replacement Surgery

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1574/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":482.35672,"timestamp":1789546124622,"preClose":496.71994,"halted":0,"volume":78292841,"delay":0,"changeRate":-0.028916,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-14.36322,"latestTime":"09-16 16:00:00","open":496.59045,"high":497.2955,"low":481.3899,"amount":2159910416.1,"amplitude":0.032021,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":3.69899,"peRate":164.598608,"turnoverRate":0.002939,"increases":11,"decrements":18,"flats":3,"marketCap":306781682880,"floatMarketCap":272645614616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":497.2955,"amplitude":0.032021,"preClose":496.71994,"low":481.3899,"pbRate":"3.69899","latestPrice":482.35672,"volume":78292841,"delay":0,"open":496.59045,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.388,"twentyDayClose":492.831,"sixtyDayClose":437.952,"secType":"PLATE","market":"HK","turnoverRate":0.002939,"peRate":164.598608,"marketCap":306781682880,"floatMarketCap":272645614616,"timestamp":1789546124622,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":12,"down":18,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194393622","title":"ZYLOXTB (02190) Spends Approximately HK$1.13 Million on Share Buyback on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1194393622","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194393622?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:39","pubTimestamp":1789465143,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 15, 2026, it expended roughly HK$1.13 million to repurchase 55,000 of its own shares.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK1574","BK1587","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185373312","title":"HK Stocks in Focus: HEART CARE-B Surges Over 5% on Robust H1 Growth and A-Share Listing Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=1185373312","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185373312?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:26","pubTimestamp":1789453575,"startTime":"0","endTime":"0","summary":"HEART CARE-B (06609) saw its share price climb more than 5% during Hong Kong trading, last up 4.86% at HK$52.20 with turnover reaching HK$2.37 million.The company recently unveiled its interim...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","REDS","03130","IPOS","KCAI","BK1147","02846","82846","KCE","BK4588","03188","83188","83130","BK4127","BK1100","399300","02827","BK4585","VXUS","FRHC","BK1587","BK1574","06609","07233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK1515","BK4588","09637","BK1574","KCAI","159938","BK1161","VXUS","BK4585","BK1191","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122495500","title":"Channel Edge Fades, Active Research Lags: Who Can Fill ICBC Credit Suisse's Equity Gap?","url":"https://stock-news.laohu8.com/highlight/detail?id=1122495500","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122495500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:20","pubTimestamp":1789449655,"startTime":"0","endTime":"0","summary":"The greatest moat for bank-affiliated fund firms lies in distribution channels, yet in the long run, that moat only moves products, it cannot substitute for research, talent, or risk...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152384150","title":"Jefferies Reaffirms Bullish Stance on AKESO, Sets Price Target at HK$226","url":"https://stock-news.laohu8.com/highlight/detail?id=1152384150","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152384150?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:21","pubTimestamp":1789446061,"startTime":"0","endTime":"0","summary":"Jefferies has released a research note indicating that the H-2 study of AKESO's (09926) Ivonescimab has yielded favorable outcomes. The data showed that the interim overall survival (OS) endpoint...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720050803.USD","IE00B5MMRT66.SGD","LU1961090484.USD","LU2476274720.SGD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348766576.USD","LU0348783233.USD","LU2476274308.USD","LU0561508036.HKD","LU0348735423.USD","LU0348784397.USD","EWH","LU0634319403.HKD","LU0348827113.USD","KURE","LU2399975544.HKD","09926","BK1161","LU0417516571.SGD","BK1574","LU0348767384.USD","LU2488822045.USD","LU0540923850.HKD","LU2778985437.USD","IE00BPRC5H50.USD","LU0417516902.SGD","LU0417516738.SGD","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124014323","title":"Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1124014323","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124014323?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:16","pubTimestamp":1789438610,"startTime":"0","endTime":"0","summary":"According to a research report released by Zheshang Securities Co.,Ltd., the external environment and internal growth drivers across medical device sub-sectors are expected to diverge in the second...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","MEDX","BK0276","GDOC","BK1583","HART","IEIH","159883","09996","BK1100","BK1574","MDEV","LNGR","601878","RSPH","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168074562","title":"Hong Kong Stock Flash | TYK Medicines-B (02410) Surges Over 10% as Major Shareholder's Buyback Lifts Sentiment, Following Key Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1168074562","media":"Stock News","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168074562?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:08","pubTimestamp":1789438099,"startTime":"0","endTime":"0","summary":"Shares of TYK MEDICINES-B (02410) climbed steadily higher this morning, trading up 10.1% at HK$3.38 by the time of writing, with turnover reaching HK$3.89 million.According to the latest data from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","BK1515","02410","BK4588","BK1574","09939","159938","BK4585","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126314596","title":"Jefferies Highlights Positive HARMONi-2 Results for AKESO, Reaffirms Buy Rating with HK$226 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1126314596","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126314596?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:00","pubTimestamp":1789437625,"startTime":"0","endTime":"0","summary":"Jefferies has released a research report indicating that AKESO (09926) achieved positive results from its HARMONi-2 study of Ivonescimab. The data showed that the interim overall survival (OS)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348784397.USD","LU0348735423.USD","LU0417516571.SGD","KURE","LU2399975544.HKD","BK1161","LU2488822045.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0348783233.USD","LU1961090484.USD","LU2778985437.USD","LU0348825331.USD","LU1720050803.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU2476274308.USD","LU0561508036.HKD","LU0417516902.SGD","LU0348827113.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0634319403.HKD","LU2476274720.SGD","LU0348766576.USD","LU0348767384.USD","09926","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110963745","title":"GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1110963745","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110963745?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:28","pubTimestamp":1789432097,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has unveiled updated efficacy data from its Phase II trial evaluating GFH375 as a monotherapy for patients with pretreated KRAS G12D-mutant non-small cell lung cancer (NSCLC). The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","02595","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","BK1183","BK1191","LU1008478684.HKD","01911","LU1813983027.USD","BK1161","LNGR","IBBQ","06978","LU0140636845.USD","IE00BZ08YT58.USD","LU1951186391.HKD","BK4588","CDMO","LU1226287792.SGD","LU0501845795.SGD","IE0008369823.USD","02889","BK4139","159992","BK1515","BK1539","BK1521","LU1226288170.HKD","LU0067412154.USD","02238","SG9999004220.SGD","IE00B543WZ88.USD","HK0000165453.HKD","IE0008368742.USD","LU1152091168.USD","LU1226287875.USD","LU0315179316.USD","MEDX","LU1993786604.SGD","LU0880133367.SGD","LU0314109678.HKD","LU1226287529.USD","LU1226288253.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","BK1147","BK4585","IE00BZ08YR35.GBP","KCAI","BK1574","LU1807302812.USD","LU1960683339.HKD","BK1119","LU2039709279.SGD","LU0072913022.USD","KURE","VXUS","01093","BK1144","IE00B5MMRT66.SGD","LU1328277881.USD","IE00B031HY20.USD","06871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164485065","title":"EDDING GENOR Spends Approximately HK$1.70 Million on Share Buyback on September 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1164485065","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164485065?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:30","pubTimestamp":1789396222,"startTime":"0","endTime":"0","summary":"EDDING GENOR has announced that on September 14, 2026, it repurchased 1 million shares at a cost of approximately HK$1.70 million.The share buyback was executed at a price range of HK$1.69 to HK$1.76...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1574","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148029930","title":"CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=1148029930","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148029930?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:11","pubTimestamp":1789395083,"startTime":"0","endTime":"0","summary":"Entering September, the CRO/CXO sector remains one of the most resilient directions within the pharmaceutical space, with capital attention once again intensifying around the entire chain spanning...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","ADC","BK1161","MEDX","LNGR","BK1574","NETL","BK4231","06978","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128920905","title":"Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=1128920905","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128920905?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:50","pubTimestamp":1789390244,"startTime":"0","endTime":"0","summary":"Hong Kong stocks showed resilience on Wednesday, dipping in early trading before recovering to close 0.45% higher despite worrying inflation signals from the US. Core CPI rose 0.3% month-on-month,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","LU1048596156.SGD","QTOC","LU0890818403.SGD","LU1719994722.HKD","BK4585","IBBQ","LU1655091616.SGD","AGIX","LU1981816686.USD","LU1251922891.USD","IE0034224299.USD","BK1566","06690","LU0348825331.USD","IE00B29SXG58.USD","LU1515016050.SGD","LU1119993845.HKD","LU1303224171.USD","MEDX","LU0737861699.HKD","BK1570","IE00B031HY20.USD","LU2476274308.USD","IE00BYV24P56.USD","LU0417516738.SGD","IE00BMCWC346.EUR","BK1557","LU0828237510.HKD","LU2048586759.USD","LU2328871848.SGD","KURE","06160","LU0287142896.SGD","BK1607","LU1969619763.USD","IE0008369823.USD","IE00BGHQDM52.EUR","BK1583","LU0431992006.USD","00135","LU0651946864.USD","LNGR","IE0008368742.USD","BK1521","BK4588","LU0348735423.USD","LU1808992512.USD","IE00BZ08YT58.USD","ARTY","CHAT","IE00B5MMRT66.SGD","LU0205439572.USD","LU0588546209.SGD","AIPO","BK1528","LU1224709979.USD","LU0593848301.USD","LU0862451753.SGD","06978","BK1574","LU0469268626.HKD","IE00BZ08YR35.GBP","LU0821914370.USD","LU0640798160.USD","BK1588","VXUS","IE00BVYPNQ40.USD","09969","BK1161","LU1770034418.SGD","IE00B543WZ88.USD","IE00BVYPNP33.GBP","LU2279701549.SGD","BK1214","BK1500","LU0877626530.USD","LU1051768304.USD","BK1221","LU0228659784.USD","159992","LU0173614495.USD","LU0307460666.USD","02688","LU1115378108.SGD","LU0417516902.SGD","LU0868486357.SGD","LU2778985437.USD","KCAI","01193","BK1589","VTHR","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157665081","title":"HEARTCARE-B Grants 560,000 Share Awards Under 2025 Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1157665081","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157665081?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:28","pubTimestamp":1789388915,"startTime":"0","endTime":"0","summary":"HEARTCARE-B (06609) has announced the granting of 560,000 share awards to eligible employees.According to the company's official statement released on September 14, 2026, the awards were issued under...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","06609","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148140095","title":"Edding Genor Board Chair and CEO Boosts Stake with 200,000-Share Purchase at $1.74 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1148140095","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148140095?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:40","pubTimestamp":1789386024,"startTime":"0","endTime":"0","summary":"Hong Kong Stock Exchange disclosures show that on September 10, Ni Xin, the Board Chairman and Chief Executive Officer, acquired 200,000 shares of Edding Genor (06998) at a per-share price of HKD...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998","BK1161","BK1583","EWH","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191852979","title":"ALPHAMAB-B (09966) Allocates Approximately HK$796,300 for Share Buyback on September 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1191852979","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191852979?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:26","pubTimestamp":1789385171,"startTime":"0","endTime":"0","summary":"In a recent corporate action, ALPHAMAB-B (09966) has disclosed its latest buyback transaction.According to the announcement, on September 14, 2026, the company expended roughly HK$796,300 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106087052","title":"Market Consolidation with Low Volume: Innovative Drugs Surge Against the Trend, Banking Index Hits New Annual High, Optical Module Leaders Retreat While Capital Seeks Opportunities in High-Optical ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=1106087052","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106087052?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:20","pubTimestamp":1789384851,"startTime":"0","endTime":"0","summary":"On Monday (September 14th), A-shares opened lower, recovered, and then retreated again into a volatile downward trend with noticeably shrinking volume. Total turnover across both markets was a mere...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK1574","BK4588","AAOX","159992","399986","BK1161","159253","AAOG","06978","MEDX","FDN","LNGR","LUMA","LYTE","BK4585","AAOZ","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143961732","title":"ETF Market Recap: Short-Term Opportunities Emerge in Previously Corrected Innovative Drug and CXO Sectors Amidst Soft Broader Market Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1143961732","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143961732?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:11","pubTimestamp":1789384292,"startTime":"0","endTime":"0","summary":"On September 14th, major A-share indices gave up early gains and weakened into the close, with the Shanghai Composite Index settling at 3885.33 points, down 0.07%; the Shenzhen Component Index...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399300","BK1147","WX","02827","BK4585","BK4588","07233","83130","02846","06978","FDN","03188","BK1574","LNGR","BK4550","IBBQ","BK1161","82846","159992","MEDX","159982","CXO","83188","03130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193173717","title":"National Healthcare Security Administration Releases Roster of Pharmaceutical Firms With 'Severe' and 'Extremely Severe' Credit Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=1193173717","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193173717?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:52","pubTimestamp":1789383153,"startTime":"0","endTime":"0","summary":"The Medical Price and Procurement Guidance Center, operating under the delegation of the National Healthcare Security Administration, has compiled and published a list of pharmaceutical enterprises...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151736324","title":"Hengrui's Novel Factor XI Monoclonal Antibody Wins NMPA Acceptance for VTE Prevention in Elective Knee Replacement Surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=1151736324","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151736324?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:31","pubTimestamp":1789381900,"startTime":"0","endTime":"0","summary":"Hengrui Pharmaceuticals' subsidiary, Beijing Shengdi Pharmaceutical Co., Ltd., has recently received the official \"Acceptance Notification\" from the National Medical Products Administration (NMPA)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","IBBQ","BK1161","LNGR","MEDX","BK1574","IPOS","159992"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":2,"totalSize":225,"code":"91000000","status":"200"}]}}